Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source

SHINIL Pharma Ltd (SPL) is one of the top kinds of company in the Animal Health sector in Bangladesh. SPL adopting the most recent technology to formulate and to produce generic formulation ensuring optimum quality compared to the international brands.

SHINIL Pharma started its operation in 1995 through establishing a company named PHARMA & FIRM in association SHINIL BIOGEN Co.,LTD. Till Now PHARMA & FIRM is  responsible for importing and distributing SHINIL  products to the local market.

Later on, in 2006 PHARMA & FIRM  decided to establish its own pharmaceutical plant named SHINIL Pharma Ltd  to produce the products those are imported from SHINIL BIOGEN CO.,Ltd , Korea  and other local generics for indigenous market.

SPL is now proposed kinds products for its own with various types of dosage forms which include Tablets (Bolus), Liquids, Water soluble powder, Injection, covering almost all therapeutic classes where a lot of products are in the launching pipeline. SPL will wishes to launch Vaccine, Hormone and Cephalosporin preparations to its product portfolio in future.

SHINIL Pharma limited is engaged with strategic marketing process which involves building customer relationships by creating and delivering superior customer value aiming to produce high customer equity. SPL successfully and efficiently blending skilled people, resources, organizational structure and decisions for implementing strategies at all levels.